Clinical Trial Update: Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Rifampicin in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating whole blood bactericidal activity of rifampicin against Mycobacterium tuberculosis in healthy volunteers. The trial status is suspend…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Rifampicin

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Tuberculosis | Phase 1 | Status: SUSPENDED